Balchem (Nasdaq: BCPC) is expected to report Q2 earnings on July 31. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Balchem's revenues will grow 9.9% and EPS will grow 18.2%.

The average estimate for revenue is $86.9 million. On the bottom line, the average EPS estimate is $0.39.

Revenue details
Last quarter, Balchem notched revenue of $84.7 million. GAAP reported sales were 11% higher than the prior-year quarter's $76.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.36. GAAP EPS of $0.36 for Q1 were 16% higher than the prior-year quarter's $0.31 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 28.6%, 80 basis points better than the prior-year quarter. Operating margin was 18.7%, 80 basis points better than the prior-year quarter. Net margin was 12.9%, 70 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $343.9 million. The average EPS estimate is $1.53.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 341 members out of 349 rating the stock outperform, and eight members rating it underperform. Among 99 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 98 give Balchem a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Balchem is outperform, with an average price target of $44.67.

The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.